Skip to main content
Przejdź do strony domowej Komisji Europejskiej (odnośnik otworzy się w nowym oknie)
polski pl
CORDIS - Wyniki badań wspieranych przez UE
CORDIS
Zawartość zarchiwizowana w dniu 2024-05-29

Use of Adipose Derived Stem Cells (ADSC) for Anal Incontinence Cell Therapy

Cel

The possibility of improving the function of organs or structures damaged in numerous pathological scenarios by the use of cellular therapies is a true clinical reality. Stem cells isolated from adult tissues are one of the tools for this new therapeutic approach. Adipose Derived Stem Cells (ADSC) have shown multipotency in vitro (differentiation into fat, bone, cartilage, muscle). Several pre-clinical studies point to the use of ADSC in cell therapies.

Anal incontinence (AI) impacts severely the quality of life of sufferers, about 2-8% of the adult population. Injury to the pudendal nerve and/or to anal sphincter muscle from prior obstetric trauma is described as the primary risk factor to develop AI. The overall aim of this project is to develop a cell therapy for AI using ADSC in an animal model of anal sphincter deficiency.

We will develop a rat model of AI by simulated birth trauma (vaginal distension + episiotomy), and will characterize the structural and functional changes of the anal sphincter by in vitro, in vivo and ex vivo studies. Then we will test the effect of cells injected in the anal sphincter in the structural and functional restoration of the anal sphincter, comparing multipotent, undifferentiated ADSC with cells differentiated into a myogenic lineage.

This project is relevant to the objectives of the Human Resources and Mobility Work Programme. This project will allow the return of a first-class European researcher back into Europe and transfer the knowledge acquired in his last eight years of research in USA, effectively reversing and cancelling the European brain drain. The applicant will join a PRO, the Cell Therapy and Regenerative Unit of the Autonoma University of Madrid, which was established in 2004 through collaboration with a Spanish SME, Cellerix.

Thus, this project will benefit the applicant's career in the prospects of durable and stable professional integration and will improve the collaborative research between PROs and SMEs.

Dziedzina nauki (EuroSciVoc)

Słowa kluczowe

Temat(-y)

Zaproszenie do składania wniosków

FP6-2004-MOBILITY-12
Zobacz inne projekty w ramach tego zaproszenia

System finansowania

IRG - Marie Curie actions-International re-integration grants

Koordynator

FUNDACION PARA LA INVESTIGACION BIOMEDICA HOSPITAL UNIVERSITARIO LA PAZ
Wkład UE
Brak danych
Adres
Paseo de la Castellana 261
MADRID
Hiszpania
Koszt całkowity
Brak danych